Tag: KAM
News alerts
Latest content
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream

- Ondine’s Steriwave phase 3 trial reaches 93% enrolment milestone

- Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease

- Alzecure shares new preclinical data on NeuroRestore ACD856 at AD/PD conference

- Samsung Bioepis signs partnership with Sandoz for next‑generation biosimilars

Contact details
PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
